GleamWall
中文EN

IVF INVO Fertility, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1417926 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY15.2%
TTM net income YoY82.9%
TTM EPS YoY138.9%
Revenue 3-yr CAGR61.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-72.2%
Net margin-59.9%
FCF margin—
EBITDA margin-64.6%

Returns

ROE-40.5%
ROA-21.6%
ROIC (approx.)-34.7%
Asset turnover0.36x

Leverage & solvency

Liabilities / assets29.4%
Debt / equity0.05x
Current ratio1.00x
Interest coverage-5.06x

Cash quality & payout

Operating cash flow / net income0.98x
Accruals ratio-0.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.22M$2.18M$2.02M$1.58M$1.76M$1.86M$1.64M$1.69M
Cost of revenue—$60,147$5,152——$3,063$3,984$1.02M
Gross profit—$2.12M$2.01M——$1.86M$1.63M$669,068
R&D expense——————$265,663$484,780
SG&A expense$2.07M$1.91M$2.18M$1.81M$2.13M$2.19M$1.56M$3.48M
Operating income-$1.48M-$1.29M-$1.59M-$1.41M-$1.64M-$2.99M-$1.20M-$1.97M
Interest expense$154,768$177,227$180,323$627,107$322,765$440,596$307,839$231,824
Pretax income-$2.12M$944,894—$1.86M-$3.40M-$1.54M-$17.40M-$3.68M
Income tax$29,530$56,154$0———$0-$54,008
Net income-$2.15M$888,740-$5.54M$2.01M-$3.40M-$3.62M-$17.40M-$3.62M
EBITDA-$1.30M-$1.14M-$1.45M-$1.28M-$1.50M-$2.82M-$965,066-$1.73M
EPS (basic)-2.440.42-3.38—-157.43-364.23-3,473.93—
EPS (diluted)-2.440.35-3.38—-157.43-364.23-3,473.93—
Weighted avg. shares (diluted)880,2332.59M1.64M—21,5699,9365,010—
Balance sheet
Cash & equivalents$0$3.73M$4.90M$0$355,891$549,181$840,407$619,520
Receivables$170,423$257,729$248,387$217,263$274,200$242,255$173,614$113,108
Inventory$230,806$251,290$224,555$225,253$191,762$212,611$216,458$219,764
Current assets$4.44M$4.60M$5.73M$2.76M$1.14M$1.40M$1.57M$1.26M
PP&E, net$814,175$832,851$474,641$386,165$405,417$428,746$451,247$466,684
Goodwill$9.24M$9.25M$6.52M$5.88M$5.88M$5.88M$8.89M$5.88M
Intangibles$1.25M$1.36M$1.37M$1.33M$1.43M$1.54M$17.90M$3.28M
Total assets$25.50M$25.83M$24.66M$20.22M$18.83M$19.32M$31.74M$46.08M
Current liabilities$4.46M$6.52M$6.36M$10.33M$9.13M$12.14M$18.72M$17.87M
Short-term debt$594,990$1.13M$1.24M$1.27M$1.03M$3.77M—$6.34M
Long-term debt$362,445$513,386$660,165$744,725$951,668$1.04M—$1.13M
Total debt$957,435$1.64M$1.90M$2.02M$1.98M$4.81M—$7.47M
Total liabilities$7.49M$9.34M$9.63M$13.00M$13.01M$16.19M$24.43M$26.04M
Shareholders' equity$18.01M$16.49M$15.02M$7.22M$5.65M-$7.15M-$27.20M$12.58M
Net debt$957,435-$2.09M-$3.00M$2.02M$1.63M$4.26M—$6.85M
Shares outstanding1.19M2.30M1.64M119,3585.42M828,110746,2273,111
Cash flow statement
Operating cash flow-$1.72M-$1.10M-$1.92M$25,207-$1.78M-$1.72M-$3.55M-$617,379
Capital expenditure$44,787——$11,823$8,062$8,877$14,650$78,874
Free cash flow-$1.76M——$13,384-$1.78M-$1.73M-$3.56M-$696,253
Investing cash flow-$44,787-$2,216-$210,000-$2.71M-$8,062-$15,446-$14,650$393,134
Financing cash flow$1.72M-$67,847$4.95M$4.40M$1.59M$1.44M$3.66M$494,050
Depreciation & amortization$177,564$145,573$142,698$136,425$136,741$169,737$234,462$231,810

Free plan shows the latest 8 periods; Pro shows all 64 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.